跳至主要内容
临床试验/NL-OMON29053
NL-OMON29053尚未招募不适用

Evaluation of the responsiveness of anti-VEGF treatment in DME

GSMS0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
GSMS
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • DME patients with completion of 6 intravitreal injections of anti-VEGF at UMCG and at least 1 year follow-up with BCVA
  • and OCT after start of the treatment will be included.

排除标准

  • high myopia (>6 diopters), glaucoma, media opacities interfering with OCT imaging,
  • combined retinal disease, intraocular surgery within 12 weeks prior to the first injection,
  • vitreomacular traction on SD-OCT and those whose SD-OCT images were of poor quality

研究者

发起方
GSMS

相似试验

进行中(未招募)
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaTreatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME)MedDRA version: 20.0Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disorders
EUCTR2020-003515-10-PLF. Hoffmann-La Roche Ltd200
进行中(未招募)
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
EUCTR2020-003515-10-ITF. HOFFMANN - LA ROCHE LTD.200
进行中(未招募)
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaTreatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME)MedDRA version: 20.0Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disorders
EUCTR2020-003515-10-CZF. Hoffmann-La Roche Ltd200
进行中(未招募)
不适用
Collection of ophthalmic data to predict the effectiveness of Anti-VEGF treatment in diabetic patients by assessing the retinal thickness using artificial intelligence tools.
CTRI/2021/05/033844Carl Zeiss India Bangalore Pvt Ltd
招募中
不适用
The effect of anti-VEGF treatments for neovascular,exudative and inflammatory ocular diseasesOcular diseases including neovascular, serous and inflammatory diseases
JPRN-UMIN000021589The department of ophthalmology,Tohoku university graduate School of Medicine3,000